Gastrostomy Tube vs Stent for Esophageal Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
The main goal of this trial is to assess whether it's feasible to conduct a larger, full-scale study comparing the use of gastrostomy (g-tubes) and stents in patients with unresectable cancer of the stomach and/or esophagus, and to evaluate their impact on patients' quality of life. Additional objectives include examining the rates of complications, the need for additional treatments, and the total number of hospital days over a three-month period.
Who Is on the Research Team?
Rahul Nayak, MD MSc
Principal Investigator
London Health Sciences Centre
Are You a Good Fit for This Trial?
This trial is for patients with inoperable esophageal or stomach cancer, specifically at the gastroesophageal junction (GEJ). It's focused on those who haven't had previous treatments that would interfere with the study. Details about specific inclusion and exclusion criteria are not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a gastrostomy tube or esophageal stent for palliation
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Gastrostomy Tube
- Self Expanding Metal Esophageal Stent
Find a Clinic Near You
Who Is Running the Clinical Trial?
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead Sponsor
London Health Sciences Centre OR Lawson Research Institute of St. Joseph's
Lead Sponsor